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Following the terrorist attacks on the
United States, governments and
funding agencies are quickly
rethinking their strategies for
detecting and combating agents that
could be used as bioweapons.
Researchers say the attention is
giving a needed boost to research
into infectious diseases.
“Bioterrorism attacks have
definitely impacted on us, giving
research a sense of urgency,” says
Brett Finlay, a microbiologist at the
University of British Columbia in
Canada. Finlay is currently helping
coordinate an effort to develop a
national agenda for the funding of
research into safe food and water.
The effort, spearheaded by the
Institute of Infection and Immunity
of the Canadian Institutes of Health
Research (CIHR; the main
government agency that funds
biomedical research in Canada),
speaks to the growing official concern
about bioterrorism involving
pathogens introduced into the food
or water supply. 
The Canadian effort is bringing
together various government
associations, academic institutes, and
other organizations to determine
each group’s funding strategies and
interests, as a first step to identifying
the priorities for funding on a broad
scale. “We want to make sure that all
the areas are covered,” says Finlay. 
Although a similar process is not
occurring in the US, major funding
agencies are refocusing their research
efforts in light of the bioterrorism
threat. In her November 14
testimony before the Committee on
Government Reform, Carole
Heilman, director of the division of
microbiology and infectious disease
for the National Institute of Allergy
and Infectious Disease at the
National Institutes of Health (NIH)
said that the agency will announce in
the next few weeks several new
initiatives for research on agents of
bioterrorism “The submission,
review, and funding of these
proposals will be expedited in order
to facilitate the rapid advance of
these important research endeavors,”
said Heilman. 
US Congress is also considering a
number of measures to increase
funding to counter bioterrorism. On
November 15, US Senators
introduced a bill that would allocate
$3.2 billion in funding for bioterrorism
preparedness — almost twice as much
as president Bush had proposed
spending. While the majority of the
money would go for helping state and
local government prepare for
bioterrorism and for stockpiling
Spray away: a researcher spreads a novel
decontaminating foam in a laboratory as a
first line of defence against biological agents.
The foam, which comprises detergents and
oxidizing agents and is not considered a risk
to humans, is being developed by Sandia
Laboratories in the US. 
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antibiotics and the smallpox vaccine,
the money will also be used to expand
research on biological agents and
toxins, as well as new treatments and
vaccines. In addition, the bill contains
a series of grants incentives to help
encourage the development of
vaccines and measures targeting the
nation’s food supply.
Increased funding might help
relieve some of what researchers see
as major limitations to microbiology
research. “More and more graduate
students who work in virology chose
to postdoc in developmental biology,
neuroscience, human genetics —
areas that have gotten more play in
the last few years,” says Don Ganem,
a virologist at the University of
California, San Francisco. Part of the
difficulty in attracting young
scientists to the field is that they are
discouraged by the lack of suitable
research facilities, according to
William Dietrich, an anthrax
researcher at Harvard Medical School. 
Several researchers say that the
study of deadly pathogens has been
hindered by the lack of specially
designed laboratories at academic
settings. In particular, very few
biosafety level 4 (BSL-4) laboratories
— which are required for research
using viruses such as Ebola — exist
worldwide. Canada has one federally
owned BSL-4 laboratory housed at
the Canadian Science Centre for
Human and Animal Health in
Winnipeg, Manitoba. There are four
existing BSL-4 labs in the US. Three
of them are at government agencies
— the CDC in Atlanta, Georgia, the
US Army base at Fort Detrick,
Maryland, and the National
Institutes of Health in Bethesda,
Maryland. The fourth is part of a $12
million facility at the Southwest
Foundation for Biomedical Research
in San Antonio, Texas, which became
functional in March of last year. 
Up to now there were no BSL-4
facilities at academic institutions. But
next February the University of
Texas Medical Branch at Galveston
will begin building a $10.5 million
facility that will include a BSL-4 lab.
It will be run by C.J. Peters, former
head of the CDC’s Special Pathogens
Branch. Several other universities
have been planning similar facilities
and research programs to study
deadly pathogens. And in the light of
recent events in the US, renewed
focus on infectious disease may help
provide needed funds to support
their plans. 
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